Two Days Dedicated to Innovation in Oncology and the Technologies of Tomorrow
On July 1–2, 2026, Cellura will participate in the 13th Annual Seminar of the Canceropôle Provence-Alpes-Côte d’Azur, held at the Palais des Congrès in Saint-Raphaël, France.
This event is one of the leading regional scientific meetings dedicated to cancer research. Each year, it brings together academic researchers, clinicians, technology platforms, hospitals, innovative startups, and industrial partners committed to advancing the next generation of cancer therapies.
For Cellura, this seminar represents a valuable opportunity to engage with the oncology research community and discuss the emerging challenges associated with 3D cell culture and the production of shear-sensitive cells.
Increasingly Complex Cellular Models
Cancer research models continue to evolve rapidly.
Tumor organoids, spheroids, immune co-cultures, stem cells, and patient-derived models now provide a far more representative view of tumor biology than conventional two-dimensional cell cultures.
However, these increasingly sophisticated models also introduce new experimental challenges:
- Preserving the integrity of fragile cells throughout the culture process.
- Maintaining homogeneous suspension of cells or microcarriers.
- Minimizing mechanical stress (shear stress) that may alter cellular physiology.
- Ensuring high experimental reproducibility.
- Facilitating scale-up from laboratory research to larger production volumes without modifying established protocols.
These challenges are now central to many research programs and represent one of the major priorities of translational medicine.
SoftXS™: A Different Approach to Cell Culture
Developed by Cellura, SoftXS™ is based on a bladeless chaotic mixing principle inspired by the natural movements of geophysical fluids.
Unlike conventional bioreactors relying on impellers or stirring blades, this approach maintains homogeneous suspension while generating extremely low shear forces, making it particularly well suited for highly sensitive cell types.
The technology offers several key advantages:
- Homogeneous suspension of cells, aggregates, and microcarriers.
- Precise control of shear stress.
- Excellent distribution of nutrients and dissolved gases throughout the culture medium.
- Simplified scale-up while maintaining identical operating parameters across different vessel volumes.
- Compatibility with a wide range of cellular models, including stem cells, organoids, immune cells, and microcarrier-based cultures.
A Technology Designed for Oncology Research
Proof-of-concept studies performed with SoftXS™ have already demonstrated its potential across several highly sensitive cell culture applications.
The platform has notably enabled:
- Expansion of induced pluripotent stem cells (iPSCs) while maintaining more than 99% pluripotency.
- Suspension culture of Natural Killer (NK) cells.
- Generation of functional organoids.
- Homogeneous resuspension of microcarriers under ultra-low shear conditions.
These results highlight the ability of SoftXS™ to support the development of advanced cellular models for fundamental, translational, and preclinical research.
Canceropôle Provence-Alpes-Côte d’Azur: A Collaborative Innovation Ecosystem
For many years, the Canceropôle Provence-Alpes-Côte d’Azur has brought together the region’s leading stakeholders in oncology research.
Its annual seminar promotes collaboration between:
- Academic research teams.
- University hospitals.
- Research institutes.
- Technology platforms.
- Innovative companies.
- Industrial partners.
This collaborative ecosystem accelerates the translation of scientific discoveries into future clinical applications.
Meet Us During the Event
During the seminar, the Cellura team will be pleased to meet researchers, engineers, technology platforms, and industrial partners interested in discussing topics including:
- 3D cell culture.
- Reducing mechanical stress on fragile cells.
- Standardization of cell culture processes.
- Scalable cell culture manufacturing.
- Applications of SoftXS™ in oncology, regenerative medicine, and bioproduction.
We will be attending the event alongside Dr. Baptiste Roumezi (CTO) to present the SoftXS™ technology and discuss the future challenges of advanced cell culture.
Building the Next Generation of Bioprocesses Together
The evolution of cellular models in oncology requires technologies capable of combining biological integrity, experimental reproducibility, and seamless scalability.
By participating in the 13th Annual Seminar of the Canceropôle Provence-Alpes-Côte d’Azur, Cellura reaffirms its commitment to supporting researchers with innovative cell culture solutions that facilitate scientific discoveries and the therapeutic innovations of tomorrow.
About the Event
More information about the 13th Annual Seminar of the Canceropôle Provence-Alpes-Côte d’Azur is available on the official website:
https://canceropole-paca.com/agenda/seminaire-annuel-2026-du-canceropole-provence-alpes-cote-dazur/
For further information or to arrange a meeting with the Cellura team during the event:
Email: contact@cellura.io
